GALMED PHARMACEUTICALS WKN: A1XFUX ISIN: IL0011313900 Kürzel: GPH Forum: Aktien Thema: Hauptdiskussion

Drüber 😊

wir müssen über 1,42$

😊

1,30$ is the key

abwarten…..

Das klingt so gut aber steigt nicht nachhaltig sondern fällt gleich wieder. Wie schade. War kurz um plus...

The top-line results from the study showed that the 3-drugs' synergistic effect has the potential as a new fixed-dose combination treatment, enhancing the effect of Bayer's top selling cancer drug, Stivarga® (regorafenib); such combination could potentially become a life-cycle IP strategy when Stivarga's® main European and U.S. patents expires in August 2028 and July 2032, respectively. New patent applications (US 63/786,370 and US 63/915,832) have been submitted to USPTO. Metformin is typically the first-choice treatment for managing type 2 diabetes and is widely available in generic forms. The combination of Aramchol and Stivarga® is expected to enter phase 1b clinical trials early 2026 in metastatic colorectal cancer (CRC), hepatocellular (HCC) and cholangiocarcinoma patients with a planned expansion cohort including metformin.

🥁

….

Galmed Announces Top-line Results in Oncology MoA Studies: A 3-drug combination of Aramchol, Stivarga® and Metformin Significantly Enhanced GI Tumor Cells, Killing In-vivo and In-vitro 🤫

Grad gute einkaufskurse oder?

War natürlich zu zeitig. 🤪

Bei 1.50 hole ich noch was dazu.

Was denn hier los....

Ich hab tatsächlich auch nur 1000St gekauft. Wer weiß, vielleicht is nochmal so ein 10 bis 20 Dollar Zock drin ...genau darauf spekulier ich. Daher nur Minimalinvest.